Global Irritable Bowel Syndrome (IBS) Therapeutics Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI365585
- May 03, 2019
- Global
- 92 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Irritable Bowel Syndrome (IBS) Therapeutics market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Irritable Bowel Syndrome (IBS) Therapeutics market."
IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.
The global Irritable Bowel Syndrome (IBS) Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Irritable Bowel Syndrome (IBS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome (IBS) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Valeant Pharmaceuticals International
Ardelyx
Astellas Pharma
Novartis
GlaxoSmithKline
Ironwood Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Blautix (Strain)
Bekinda (IBS-D)
SYN-010
Tenapanor
Segment by Application
Hospital
Research
Table of Contents
Executive Summary
1 Irritable Bowel Syndrome (IBS) Therapeutics Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome (IBS) Therapeutics
1.2 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Blautix (Strain)
1.2.3 Bekinda (IBS-D)
1.2.4 SYN-010
1.2.5 Tenapanor
1.3 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Application
1.3.1 Irritable Bowel Syndrome (IBS) Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Research
1.4 Global Irritable Bowel Syndrome (IBS) Therapeutics Market by Region
1.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size
1.5.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue (2014-2025)
1.5.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Production (2014-2025)
2 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Competition by Manufacturers
2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Production Sites, Area Served, Product Types
2.5 Irritable Bowel Syndrome (IBS) Therapeutics Market Competitive Situation and Trends
2.5.1 Irritable Bowel Syndrome (IBS) Therapeutics Market Concentration Rate
2.5.2 Irritable Bowel Syndrome (IBS) Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Regions
3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Regions
3.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions (2014-2019)
...
| read more...
Related Reports
